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Introduction 51
Dental caries affects both children and adults, and is regarded as one of the 52 most common bacterial infections in humans (Aas, Paster, Stokes, Olsen, & Dewhirst, 53 2005) . Individuals are susceptible to this disease throughout their lifetime (Sewitz, 54 considerable interest as it has become evident that many of its constituents exhibit 76 bioactive properties (Marshall, 2004) . Whey protein is made up of β-lactoglobulin 77 (50%), α-lactalbumin (20-25%), bovine serum albumin (10-15%), immunoglobulins 78 (10-15%), lactoferrin (0.35 to 2%) and lactoperoxidase (0.25-0.5%) (Madureira, 79 Pereira, Gomes, Pintado, & Malcata, 2007) . Also, sweet whey contains 80 glycomacropeptide (GMP) at concentrations of up to 15% (Madureira et al., 2007) . 81
Peptides derived from these precursor proteins are known to have antibacterial 82
properties (Madureira et al., 2007) , with enzymatic digestion being the most common 83 method used to produce such peptides (Kurhonen, 2009 ). In addition, it has been 84 reported that peptides possessing antibacterial activity can also exhibit other 85 biological activities relating to protection of the host (Lopez-Exposito & Recio, 2006) . 86
Peptide-based therapeutic agents from natural substrates (such as dairy products) that 87 can be added to food, toothpaste and mouthrinses are increasingly in demand as an 88 approach to delay progression of caries (Hayes, Ross, Fitzgerald, Hill, & Stanton, 89 2006) . 90
A non-protein constituent of whey which may contribute to its bioactive 91 properties is milkfat. This component may also have potential to inhibit dental caries, 92 as it contains triglycerides and lipids that can exhibit antimicrobial effects either 93 directly or following enzymatic digestion (Sprong, Hulstein, & van der Meer, 2002) . 94
The spectrum of saturated fatty acids in milkfat can vary in chain-length from C 4 to 95 C 18 , while also containing the unsaturated fatty acids C 18:1 and C 18:2 (Sprong, Hulstein, 96 & van der Meer, 2001) . It has been reported that the medium-chain fatty acids C 8 -97 C 12 can have a bacteriostatic effect on dental plaque bacteria (Schuster, 1980) . 98
Research recently carried out in this laboratory has shown a range of 99 commercial dairy powders (including whey products such as whey protein 100 concentrates and whey protein isolates, along with buttermilk powder and cream 101 powder) are capable of inhibiting adherence of S. mutans to hydroxylapatite (HA) 102 (Halpin et al., 2008) . HA is a calcium-phosphate analogue of teeth commonly used as 103 an in vitro model (Gibbons, Moreno, & Spinell, 1976 , Clark & Gibbons, 1977 , Gaines 104 et al., 2003 of adherence of oral bacteria to tooth surfaces. Also, it has been claimed 105 that a commercial whey product (Carbelac 80) can inhibit both growth and adherence 106 of S. mutans following treatment with porcine pancreatic lipase (PPL) (Brady & 107 Folan, 2003) . Further to this, a separate study by Halpin, Brady, O'Riordan, & 108 O'Sullivan (2009) showed a range of commercial whey products reduced association 109 of enteric pathogens to CaCo-2 cells, and that the anti-adherence effect was enhanced 110 following PPL-treatment of the whey products. 111
As whey contains both protein and fat, enzymatic digestion can potentially 112 liberate an array of peptides and fatty acids, respectively. In the present study, a varied 113 range of whey and dairy products which were previously found to effectively reduce 114 adherence of S. mutans to phosphate-buffered saline-coated HA (PBS-HA) (Halpin et 115 al., 2008) were subjected to enzyme-treatment in order to determine if this would 116 increase their anti-adhesion activity. Therefore, the main objective of the present 117 study was to examine the effect of enzyme-treatment on the anti-adhesion efficacy of 118 these dairy powders, using both PBS-HA and saliva-coated HA (S-HA). Association 119 of the proteinaceous component of a selection of dairy powders to HA beads was also 120 investigated. In addition, the effect of both untreated and enzyme-treated dairy 121 powders on the growth of S. mutans was examined. 122
Materials and Methods 123
Bacterial Isolates and Growth Conditions 124
Ireland). The principal differences in composition between SWPC80 and SWPC35 138 should be noted. Although both of these whey products are derived from sweet whey, 139 SWPC80 contains 80% protein (i.e. 80 grams of protein per 100g of product) and only 140 6% lactose (i.e. 6 grams of lactose per 100g of product). However, SWPC35 contains 141 almost 35% protein and approximately 51% lactose. In addition, SWPC35 contains 142 only half of the amount of fat that is present in SWPC80 (refer to Compositional analysis was performed on each dairy product using standard methods. 147
Ash content was analysed according to Malkomesius & Nehring (1951) . Fat content 148 was determined according to the method of Röse-Gottlieb (International Dairy 7 Federation, IDF, 1987), protein content was determined by the Kjeldahl method (IDF, 150 1993a) and the moisture content was determined by the IDF reference method (IDF, 151 1993b Hampshire, England) was prepared by suspension of 7.5mg mL -1 HA in PBS 174 immediately before use in the adherence assays. 175
Saliva-coated-HA (S-HA) was prepared by a modification of the protocol set out by 176
Gibbons & Etherden (1982) as follows: parafilm-stimulated whole saliva was 177 collected in an ice-chilled tube from two healthy donors (1 male, 1 female) at least 1 h 178 after eating, drinking or brushing of teeth. The saliva was heated at 60ºC for 30 min to 179 inactivate degenerative enzymes, and subsequently centrifuged at 12,000 × g for 15 180 min. The pellet was discarded and the supernatant (i.e. clarified whole saliva) was 181 used to prepare a 7.5mg mL -1 dispersion of HA. Aliquots (150μL) of saliva-coated 182 hydroxylapatite (S-HA) were dispensed into the wells of a 96-well V-bottomed plate 183 (Sarstedt, Newton, North Carolina, USA), and incubated at 30ºC for 1 h with gentle 184 agitation (4.5 × g). Following this, the microtitre plate was centrifuged at 805 × g for 185 2 min, the supernatants discarded and the S-HA pellets washed twice with sterile pre-186 warmed PBS to remove excess saliva. The S-HA pellets were subsequently 187 resuspended in sterile PBS for use in the adherence assay. 188
(b) Preparation of Syto 13 dye 189
Syto 13 dye (Molecular Probes, Oregon, USA) was supplied as a 5mmol L -1 190 solution in dimethylsulphoxide (DMSO). This concentration was adjusted to 5μmol L -191 1 by appropriate dilution in sterile PBS, and was used only on the day of preparation. 192 A standard curve of relative fluorescent units (RFU) versus CFU mL -1 was 193 constructed for S. mutans (R 2 = 0.9942). 194
Assay Protocol 195
An overnight culture of S. mutans was centrifuged at 3220 × g (Eppendorf 5810R, 196 Cambridge, UK) for 10 min and the pellet resuspended in sterile PBS. Following a 197 second centrifugation step, the bacterial pellet was resuspended in PBS, and the 9 OD 630nm of the suspension measured using a Multiskan Ascent spectrophotometer 199 ((Thermo Electron Corporation, Vantaa, Finland), and adjusted to 0.2 by appropriate 200 dilution with sterile PBS. 201
The adherence assays were carried out as previously described (Halpin et al., 2008) , 202 using sterile 96-well polystyrene microtitre half-area plates (Nunc, Roskilde, 203 Denmark). Dairy powders were prepared to the required concentration by dispersing 204 the dried powder in PBS. Briefly, 50μL of test material solution at various 205 concentrations was added to the wells, followed by 50μL of PBS-HA or S-HA (7.5 206 mg mL -1 ). Bacterial suspension (50μL) was added to the wells, so that the final 207 volume of each well was 150μL. Control wells (no bacteria and/ or no HA) were 208 included in each assay. The plate was incubated at room temperature for 45 min, and 209 manually inverted at 5 min intervals to prevent settling of the HA suspension. The 210 plate was subsequently centrifuged at 201 × g to sediment the HA and any adhering 211 bacteria, leaving the non-adhering bacteria in suspension. These non-adhering bacteria 212 were labelled with 10μL of 5μmol L -1 Syto® fluorescent dye. For more information 213 regarding the development and validation of the assay described here, the reader 214 should refer to Halpin et al., 2008. 215 
Quantification of Bacterial Adherence 216
Aliquots (100μL) of supernatant from the adherence assay (Section 2.4.2) containing 217 the non-adhering bacteria were transferred from each well of the half-area plate to the 218 corresponding wells of a black microtitre plate (Costar, Corning Inc., Corning, USA). 219
This plate was allowed to stand at room temperature for 5 min in the dark before 220 reading the fluorescence using a Fluoroskan Ascent plate reader (Thermo Electron  221 Corporation, Vantaa, Finland). The excitation wavelength was 485 nm and the 222 emission intensity was monitored at 538 nm. Three measurements were taken at 5 min 223 intervals, and the average fluorescence calculated. The fluorescence due to the total 224 number of bacteria present in the supernatant was determined as a direct readout from 225 the fluorimeter as relative fluorescent units (RFU). The background fluorescence due 226 to non-bacterial components of the assay (i.e. dairy powder and HA) were subtracted. 227
The percentage inhibition of adhesion was calculated as follows: 228
Fluorescence due to unbound bacteria
Fluorescence due tototal input bacteria × 100 (1) 229
Protein Adherence Assay 230
The ability of the proteinaceous component of the various dairy powders to adhere to 231 the HA beads was assessed as follows; a dispersion of HA (20 mg mL -1 ) was mixed 232 with an equal volume of test material at various concentrations, so that the final 233 concentration of test material ranged from 0.0625mg mL -1 to 1mg mL -1 . The mixture 234 was gently inverted at 5 min intervals for a period of 45 min, before being centrifuged 235 (201 × g, 10 min). Supernatants were subsequently decanted into plastic tubes and 236 shaken vigorously before determination of protein content by the bicinchonic acid 237 (BCA) method (Smith et al., 1986) , for which all reagents were supplied by Sigma 238 (Poole, Dorset, UK). Aliquots (25μL) of supernatant were added to wells of a 96-well 239 plate, followed by 200μL of BCA reagent, and the plate was subsequently incubated 240 for 30 min at 37˚C. A plate reader (Spectra Max; Molecular Devices Corp., U.K.) was 241 used to measure sample absorbance values. Absorbance was measured at 570nm 242 (Abs 570nm ), and readings were converted to mg mL -1 protein using a standard curve of 243 absorbance versus protein concentration (R 2 = 0.9983), which was prepared using 244 bovine serum albumin (BSA; Sigma, Poole, Dorset, UK). 245
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 246
To investigate the selectivity of any HA/ protein interactions, the protein profiles of 247 the resulting supernatants from the protein adherence assay were compared to that of 248 the starting material by SDS-PAGE (Laemmli, 1970) using the Bio-Rad protein mini-249 gel system (Bio-Rad Laboratories, Richmond, California). Briefly, this was achieved 250 by incubating untreated WPCs with HA beads or alone (as described in Section 2.6). 251
Sedimentation recovered the HA beads along with any bound protein, leaving 252 unbound protein in the supernatant which was quantified using SDS-PAGE. All 253 reagents were purchased from Sigma (Poole, Dorset, UK). Resolving gel and stacking 254 gel were prepared to 15g/100mL and 4g/100mL acrylamide, respectively. In order to 255 visualise protein bands, gels were stained using coomassie blue dye. Protein bands 256 were quantified using densitometry software (Alphaview Version 1.3.0.7, Innovatech 257 Corporation). 258
Growth Assays 259
Growth assays were carried out in sterile 96-well plates (Nunc, Roskilde, Denmark). 260
Overnight cultures of S. mutans were prepared in BHI broth as described earlier 261 (Section 2.1). A working culture containing c. 10 8 colony forming units per millilitre 262 (CFU mL -1 ) was prepared by adding 1mL of overnight culture to 9mL of sterile BHI 263 broth. Test materials were prepared by dispersing dried dairy powders or hydrolysates 264 in BHI broth to the desired concentration. Aliquots (100μL) of test material were 265 added to the wells of the plate, followed by 100μL of the diluted culture; the final 266 concentrations of test material were 0.6mg mL -1 , 1.25mg mL -1 , 2.5mg mL -1 and 5mg 267 mL -1 . Bacterial growth in the absence of test material (i.e. control growth) was also 268 determined. The plate was then incubated at 37˚C for 18 h in a Multiskan Ascent plate 269 reader (Thermo Electron Corporation, Vantaa, Finland). Immediately prior to 270 incubation the plate was shaken for 1 min in order to disperse the suspensions. The optical density (OD) readings at 630nm for each well were subsequently recorded at 1 272 h intervals, with the plate being shaken for 30 s immediately prior to measurement. 273
The initial OD reading, recorded at time 0, of each well was subtracted from all other 274 readings for the corresponding wells over the 18 h incubation time (i.e. to subtract the 275 background OD values). Hydrogen was used as a carrier gas at a flow rate of 8mL min -1 . The column 286 temperature was 140˚C and the injection block was set at 300 ˚C. The volatile SCFAs 287 (C 4 and C 6 ) present in the aqueous dairy powder hydrolysate (20 g L -1 ) samples were 288 measured by SPME headspace analysis using iso-butanoic (iso-C 4 ) and 4-methyl-289 pentanoic acids (4-Me-C 5 ) as internal standards (IS), respectively, at various time-290 points after addition of the PPL. The SPME fibres (Carboxen/ PDMS, 75μM 291 thickness) were obtained from Supelco (Supelco-Aldrich, Dublin, Ireland) and were 292 conditioned under a flow of nitrogen (10mL min -1 ) at 300˚C for 2.5h prior to use. 293
An aliquot (20 mL) of the hydrolysate was transferred to a 10 mL screw thread glass 294 vial, fitted with a magnetic stirring bar. After sealing the vial with a 295 polytetrafluoroethylene (PTFE) silicone rubber septum, the SPME needle was inserted through the latter so as to position the fibre 15 mm above the surface of the 297 liquid hydrolysate. The hydrolysate was heated with stirring by placing the vial in a 298 thermostatically controlled water bath at 50˚C. After equilibration for 10 min, the 299 headspace was sampled by exposing the fibre for 10 min. The concentration of the 300 volatile fatty acids (VFAs) was determined using the following equation: 301 302 Concentration of analyte (C 4 or C 6 ) 303 = peak area of analyte × concentration IS peak area of IS × response factor × sample volume
(2) 304
The response factors for the two analytes were established by carrying out SPME 305 headspace analysis of an aqueous standard (0.2g L -1 each of C 4 , iso-C 4 , C 6 and 4-Me-306 C 5 acids) under the same conditions as described above for the liquid hydrolysate 307 samples. 308
Response factor (C 4 or C 6 ) = 4 4 peak area C peak area iso-C or 6 5 peak area C peak area 4-Me-C
(3) 309
The response factor was calculated as 1 for both C 4 and C 6 . GC retention times of the 310 SCFAs were 2.2, 2.8, 5.6 and 6.6 min for iso-C 4 , C 4 , 4-Me-C 5 and C 6 , respectively. 311
Statistical Analysis 312
All adherence/ growth assays were performed at least three times (n=3). Results were 313 expressed as the mean ± standard deviation (S.D.). Differences between 314 concentrations within treatments were determined using the least significant 315 difference (LSD) test, while differences between treatments were determined using 316
Duncan's test. Both analyses were performed using SAS Version 9.1.3. Data were 317 considered significantly different if P<0.05. 318
Results 319
Compositional analysis of the dairy powders (fat, protein, moisture, ash and lactose) 320 was determined (Table 1) . These were typical of their product types. Sweet and acid 321
WPC80s have similar protein and fat contents, while WPI has almost no fat. WP and 322 DW contain less protein and fat than the WPCs and WPI, but have a high content of 323 lactose. SWPC35 also contains high levels of lactose when compared to the 324 WPC80's, WPI and CP. BMP contained less protein than the WPCs and WPI, and CP 325 had the highest fat content of the test materials. 326
Adherence Assays 327 (a) Adhesion to phosphate buffered saline-coated hydroxylapatite 328
A small proportion of S. mutans did not bind to PBS-HA (c. 15%) under our 329 experimental conditions (shown as the 'control' value in Table 2 ). Of the untreated 330 dairy powders, AWPC80 appeared to be the most effective inhibitor of S. mutans 331 adhesion to PBS-HA at the concentrations examined (Table 2) , increasing the non-332 binding proportion of bacteria to c. 93%. However, at 125µg mL -1 , UT BMP and UT 333 CP were equally as effective (P>0.05). The protein control, egg albumin, did not 334 reduce adhesion at all, and resulted in similar non-binding proportions of S. mutans as 335 were observed in the absence of test material (i.e. control adherence). 336
In most cases, enzyme treatment was found to reduce the anti-adhesion activity of all 337 dairy powders (Table 2), in that the proportion of non-binding bacteria was markedly 338 lower for the ET dairy powders than those observed for the equivalent UT samples. At 339 125μg mL -1 , enzyme treatment significantly (P<0.05) reduced the anti-adhesion 340 activity of all dairy powders with the exception of WP. None of the enzyme-treated 341 dairy powders caused the non-binding proportion of S. mutans to increase to levels 342 ≥40% in the PBS-HA assays. ET CP was the most potent inhibitor of S. mutans adhesion to PBS-HA at 31.25μg mL -1 , and ET CP and ET SWPC80 were found to be 344 equally as effective (P>0.05) inhibitors at 62.5µg mL -1 and 125µg mL -1 . 345
Lactose, which was present in all test materials at varying levels, was not found to 346 affect adherence of S. mutans to PBS-HA, even when used at concentrations up to 347 1000μg mL -1 (data not shown), and in fact was found to significantly increase the 348 adherence of S. mutans to PBS-HA (P<0.05). 349
(b) Adhesion to saliva-coated hydroxylapatite 350
In the presence of saliva, the control level of adhesion of S. mutans to hydroxylapatite 351 was significantly reduced when compared to that of the PBS-HA model (P<0.0001), 352 with c. 37% of each bacterial culture not adhering to S-HA ('control' in Table 3 ). Consistent with our observations in the PBS-HA model system, untreated dairy 360 powders were generally more potent inhibitors of S. mutans adherence than the same 361 powders following enzyme-treatment, except in the case of the WPCs, which were 362 found to show similar levels of efficacy both in their untreated and enzyme-treated 363 forms. However, it is worthwhile to note that the reduction in anti-adhesion activity 364 caused by enzyme treatment of powders was not as dramatic in the case of S-HA as 365 that observed in the PBS-HA model. Following enzyme treatment, at 31.25µg mL -1 , 366 all powders excluding ET WPI, ET WP and ET DW significantly inhibited adherence 367 of S. mutans to S-HA relative to the control (P<0.05). However, at 125µg mL -1 , all enzyme treated dairy powders were more effective than egg albumin (P<0.05), with 369 most ET dairy powders showing similar levels of anti-adhesion. 370
Adherence of Whey and Dairy Powders to PBS-HA 371
The more effective inhibitors of S. mutans adherence to PBS-HA were used to 372 establish if protein present in the test material was adhering to the HA beads. Table 4  373 shows the relationship between the initial protein concentrations of these dairy 374 suspensions and the amount of protein associated with HA. When sedimented from 375 solutions of increased protein content, the amount of protein associated to the HA 376 increased with increasing protein concentration in all cases, but to different extents, 377 perhaps suggesting dairy powders possessed different affinities for HA. Of the 378 materials examined, the greatest level of protein association was observed in the case 379 of AWPC80, which was also observed to be the most potent inhibitor of S. mutans 380 adherence to PBS-HA (Table 2) . 381
SDS-PAGE of Protein Content of WPC Supernatants Before and After 382
Incubation with PBS-HA 383
The electrophoresis patterns of UT SWPC80, UT AWPC80 and UT SWPC35 before 384 and after incubation with and separation from HA are compared in Figure 1 . 385 Densitometric analysis of the protein bands confirmed that the total protein content of 386 each WPC was reduced following incubation with HA. Protein contents of UT 387 SWPC80, UT AWPC80 and UT SWPC35 were reduced by 66.7%, 53.9% and 59.4%, 388 respectively. Most notably, the larger proteins (possibly the heavy and light chains of 389 the immunoglobulins and BSA) appeared to have associated with HA, as these bands 390 are not present following incubation with HA. 391
In addition, densitometric analysis indicated that the protein bands representing β-lac 392 were reduced by 51%, 41% and 63.2% for UT SWPC80, UT AWPC80 and UT SWPC35, respectively. No reduction in intensity was observed for the bands 394 representing α-lac following incubation with HA, suggesting this whey protein did 395 not adhere to the HA beads. 396
Growth Inhibition Assays 397
None of the untreated (UT) dairy powders inhibited growth of S. mutans at any of the 398 concentrations examined (0.6-5mg mL -1 ) (data not shown). Of the ET dairy powders, 399 growth inhibition of S. mutans was most evident for ET SWPC80 (Figure 2 ). Growth 400 of S. mutans was significantly inhibited (P<0.05) at all concentrations examined, and 401 the effect showed a slight concentration dependency Comparison of the rates of 402 increase of OD 630 during the logarithmic growth phase suggests that the maximum 403 concentration of ET SWPC80 (5mg mL -1 ) used reduced the rate of growth by more 404 than 2-fold over that of the control. 405
Determination of Volatile Fatty Acids in ET SWPC80 406
Aqueous hydrolysate samples were taken at 15 min intervals following addition of 407 lipase solution and SPME/GC performed at each time point. Levels of C 4 and C 6 408 appeared to 'level off' after c. 60 min, and were present at levels of 52.28 ± 6.68μg 409 mL -1 and 18.66 ± 1.49μg mL -1 , respectively, after 120 mins of hydrolysis time. 410
Discussion 411
The findings of a previous study by this group showed that a range of UT dairy 412 powders reduced adherence of S. mutans to PBS-HA (Halpin et al., 2008) . The 413 present study examined the effect of enzyme-treatment on the anti-adhesion activity 414 of these powders, using two model systems: PBS-HA and S-HA. The S-HA model 415 represents the closest approximation to conditions in the oral cavity, while the PBS 416 model system represents a cleaner working matrix and may also serve as a model for in vivo conditions where saliva production is impaired, e.g. in cases of 'dry mouth '. 418 Dry mouth, also referred to as xerostomia, describes a variety of conditions whereby 419 salivary flow rate is reduced, and individuals with this condition are susceptible to 420 rampant caries (Loesche, 1986) . The authors do however acknowledge that dry 421 mouth patients do not have teeth free from a protein film (so called 'pellicle') and 422 bacterial biofilm, but that the proteins adhering to the tooth tissues are of origins other 423 than saliva, i.e. gingival pockets, exudate from the soft tissues, and of course, foods. 424
Under our experimental conditions, control adherence varied greatly between PBS-425 HA and S-HA, which resulted in a different 'starting point' as such for assessing the 426 efficacy of the test materials. The more effective test materials (UT AWPC80, UT 427 SWPC80, UT BMP and UT CP) increased the proportion of S. mutans not adhering to 428 PBS-HA to a level similar to or greater than those observed in the presence of saliva. 429
For example, control adherence of S. mutans was typically 40% for S-HA, and the 430 proportion of bacteria not adhering to PBS-HA far exceeded this value in the presence 431 of the dairy powders listed above. Thus, dairy powders may be useful ingredients in 432 the development of a beverage which could potentially act as a saliva substitute. It has 433 previously been reported (Johansson, 2002 ) that milk and dairy-based drinks possess 434 many of the biological and physical attributes that would make them suitable saliva 435 substitutes, and the current investigation provides substantiating evidence that this 436 may be a useful application for dairy products. 437
Experiments have shown that proteins present in these dairy powders are 438 interacting with the HA beads and this may, in part at least, be contributing to the 439 reduction in adherence of S. mutans to PBS-HA. This observation was confirmed by 440 results from SDS-PAGE, which further suggested that some of the larger proteins in 441 the WPCs such as the immunoglobulins and BSA had associated with the HA beads.
Of the UT dairy powders, AWPC80 was found to be the most effective inhibitor of S. 443 mutans adhesion to HA, and exhibited the highest level of protein association with 444 HA beads. However, the level of protein associating with HA varied between test 445 materials, and a high protein content did not necessarily lead to higher levels of 446 interaction with HA beads, suggesting other factors were contributing to inhibition of 447 adherence. Furthermore, it is possible that the test materials are also interacting with 448 the bacterial cells, and this may in turn reduce the ability of the cells to adhere to 449 surfaces. 450
Although UT AWPC80, UT SWPC80, UT BMP and UT CP were found to be 451 very effective inhibitors of S. mutans adherence to both PBS-HA and S-HA, the active 452 component(s) of each of these test materials may not be the same. To begin with, the 453 compositions of these dairy powders are quite different, and this may have had a 454 direct influence on their level of anti-adhesion activity. The inhibitory effect may even 455 be due to multiple factors acting synergistically within a particular test material. Also, 456 these dairy powders exhibited varying levels of efficacy depending on (a) whether 457 they were used in PBS-HA or S-HA systems and (b) whether they had been subjected 458 to enzyme treatment. The latter is further complicated by the fact that the enzyme 459 used throughout this study was a crude PPL mixture, that contains both protease and 460 lipase constituents (Birner-Grunberger, Scholze, Faber, & Hermetter, 2003), which 461 could hydrolyse protein and fat components of the dairy powders, respectively. 462
If protein levels of each test material are compared, WPI contains the highest 463 level of protein, yet was found to be a poor inhibitor of S. mutans adhesion to HA. 464 AWPC80 contains less protein than WPI, but exhibited high levels of anti-adhesion 465 activity. Interestingly, SWPC80 contains almost the same level of protein as 466 AWPC80, but was a less effective inhibitor than AWPC80. However, the lactose content of SWPC80 was almost three times greater than that of AWPC80, and may 468 have been detrimental to the anti-adhesion activity of this dairy powder. Results from 469 the present study show that lactose promoted adherence of S. mutans to PBS-HA 470 (Table 2) , and this may help explain why powders with high lactose contents (WP and 471 DW) exhibited poor anti-adhesion activity. Further to this, it could be speculated that 472 these dairy powders did indeed possess some anti-adhesion activity but this may have 473 been negated by their high lactose content. On the other hand, BMP and CP contained 474 lower levels of protein than both AWPC80 and SWPC80, and also had considerable 475 lactose levels, yet these dairy powders were potent inhibitors of S. mutans adherence 476 to HA. It is worthwhile to note that these dairy products (BMP and CP) contain 477 caseins, which are well known to inhibit adherence of S. mutans to HA (Vacca- Smith, 478 Van Wuyckhuyse, Tabak, & Bowen, 1994). It may be the case that whey protein(s) is 479 responsible for the inhibitory activity exhibited by the WPC80s, while casein fractions 480 may be contributing to the anti-adhesion activity caused by BMP and CP. Another 481 possible explanation for the variation in the anti-adherence activity of the various 482 powders may be the differences in fat content, in that in general, only the powders 483 with fat contents higher than c. 8% exhibited high levels of inhibition. Furthermore, it 484 could be speculated that anti-adhesion activity of any dairy powder is due to the 485 presence of both protein and fat, and it may be the case that fat is required in order for 486 protein(s) to effectively associate with HA and consequently reduce adherence of S. 487 mutans, as evidenced by the greater level of association of protein to HA in the case 488 of AWPC80 than was observed for WPI. 489
At the outset of this study, it was anticipated that enzyme treatment would 490 enhance the anti-adhesion efficacy of the dairy powders, as a patent by Brady & Folan 491 product were activated upon hydrolysis. In addition, it has been reported that certain 493 antimicrobial substances present in milk and dairy-based products (such as peptides 494 and fatty acids) only become active following enzymatic digestion (Lopez-Exposito & 495 Recio, 2006) . However, in the present study the anti-adhesion efficacy of all dairy 496 powders was, in general, reduced following enzyme-treatment for both PBS-HA and 497 S-HA. For the S-HA assays, the efficacy of SWPC80, AWPC80, SWPC35 and CP 498 was slightly (but not necessarily significantly) increased by enzyme treatment at the 499 maximum concentration (125μg mL -1 ) only. Lower levels of anti-adhesion activity 500 following enzyme treatment may have been due to hydrolysis of proteins and/ or fats, 501 as no consistent trend was observed in order to determine whether protein or fat 502 digestion caused the reduction in efficacy. 503 A previous investigation by this research group which sought to determine the 504 effect of a range of whey products on the adherence of foodborne pathogens to 505 intestinal cells found that hydrolysis generally increased the inhibitory activity of 506 these test materials (Halpin et al., 2009 ). However, the study in question employed a 507 model system in which bacterial cells were incubated with epithelial cells, unlike the 508 present study where bacteria were incubated with a mineral surface (hydroxylapatite) 509 in the presence and absence of saliva. Thus, it may be that the efficacy of test 510 materials, and hydrolysates thereof, is dependent on the surface to which 511 microorganisms are adhering to. 512
Another aspect of the present study was to examine the effect of various dairy 513 powders on the growth of S. mutans. Of the range of test materials, only ET SWPC80 514 caused a substantial and significant (P<0.05) reduction in the growth of S. mutans. 515 SPME/GC analysis confirmed the presence of the free fatty acids butyric (C 4 ) and 516 caproic (C 6 ) acids in the SWPC80 hydrolysates, and it is possible that other FAs were present in the hydrolysed product, as milkfat contains a broad spectrum of FAs. 518
Studies by Sprong et al. (2001 Sprong et al. ( , 2002 have demonstrated the antibacterial activity of 519 milk-lipids. However, the inhibitory activity of ET SWPC80 could equally be due to 520 peptides produced during enzymatic digestion. characterisation of dairy-derived bioactive peptides that can be added to products such 534 as toothpastes, gels and mouth rinses (Aimutis, 2004) . Our results show that an 535 enzyme-treated whey product exhibits antibacterial effects, without isolation of 536 individual peptides or FAs. Therefore, an antibacterial agent can be produced from 537 whey, which is available in large quantities and is relatively inexpensive. 538
In conclusion, the results presented here have shown that UT dairy powders 539 are effective inhibitors of S. mutans adherence to both PBS-HA and S-HA. In general, 540 the anti-adhesion efficacy of these dairy powders was, for the most part, reduced 541 following enzyme-treatment. However, some activity was observed following enzymatic digestion, in particular for AWPC80, SWPC80, CP and BMP in both PBS-543 HA and S-HA assays. It was also evident that ET SWPC80 is an effective 544 antimicrobial agent active against S. mutans. An interesting observation of the present 545 study is that although hydrolysis of a particular whey product may on the one hand 546 increase the antimicrobial activity, it may do so at the expense of the potential anti-547 adhesion activity of the product. In other words, enzyme-treatment of dairy products 548 may enhance antimicrobial activity while suppressing their anti-adhesion efficacy. 549
Nonetheless, this present study has shown that dairy powders, which are natural 550 products and are readily available and relatively inexpensive materials, may offer 551 protection against caries in both normal and dry-mouth contexts. 
